Innovation Pharmaceuticals Inc (IPIX)

[DaubersUP]

“With these things in mind, we think our shareholders will be pleased to know that we have filed an S-3 with the SEC to solidify our financial position for the years to come. Simply, we have plenty of cash on hand and available to us for our planned laboratory and clinical studies, but a shelf registration with a few year term affords us the opportunity to explore other future considerations that are immediately accretive to our corporate value, whether it is additional clinical trials or an acquisition. We’re under no pressure to ever exercise the registration, but it is a prudent financial move to have additional cash available to us should a unique opportunity arise

. - See more at: http://cellceutix.com/cellceutixs-new-chief-operating-officer-dr-james-alexander-addresses-shareholders/#sthash.ozQWjWaI.dpuf

From the same PR:

Moving forward, we are planning IND filings for defensin-mimetics with antifungal activity as well as activity against resistant Gram negative pathogens.

I don't think you can file an IND without proof of where the funds will come from to support these future trials. I think the shelf is just that or is a baby step to getting to that. I know per the 10-K we were good up until ABOUT June with finances... But I am not sure if that included all of these new IND's for anti-fungals?

IMO - these guy's have not led us astray and have more than anyone here invested. Great leaders and management. I am 100% behind them.